Pancreatic Cancer Research

ResearcherAmsterdam University Medical CentersActive in the last 2 years

Laurien G. P. H. Vroomen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0932-092X; OpenAlex author ID A5082877479. Sources: OpenAlex.

Their work

Papers
9 (first author 4, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2017: 2 papers · 2018: 1 paper · 2019: 2 papers · 2020: 2 papers · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 9

  1. Systemic immunomodulation by irreversible electroporation versus stereotactic ablative body radiotherapy in locally advanced pancreatic cancer: the CROSSFIRE t… Co-author DOI 10.1136/jitc-2024-010222↗
  2. MRI-guided stereotactic ablative body radiotherapy versus CT-guided percutaneous irreversible electroporation for locally advanced pancreatic cancer (CROSSFIRE… Co-author DOI 10.1016/s2468-1253(24)00017-7↗
  3. Value of CT-Guided Percutaneous Irreversible Electroporation Added to FOLFIRINOX Chemotherapy in Locally Advanced Pancreatic Cancer: A Post Hoc Comparison. First author DOI 10.1016/j.jvir.2020.02.024↗
  4. Percutaneous Irreversible Electroporation in Locally Advanced and Recurrent Pancreatic Cancer (PANFIRE-2): A Multicenter, Prospective, Single-Arm, Phase II Stu… First author DOI 10.1148/radiol.2019191109↗
  5. Exocrine pancreatic and enterocyte function in patients with advanced pancreatic cancer. Co-author DOI 10.1016/j.clnu.2018.12.005↗
  6. Irreversible electroporation of locally advanced pancreatic cancer transiently alleviates immune suppression and creates a window for antitumor T cell activati… Co-author DOI 10.1080/2162402x.2019.1652532↗
  7. Locally Advanced Pancreatic Cancer: A Review of Local Ablative Therapies. First author DOI 10.3390/cancers10010016↗
  8. MR and CT imaging characteristics and ablation zone volumetry of locally advanced pancreatic cancer treated with irreversible electroporation. Co-author DOI 10.1007/s00330-016-4581-2↗
  9. Ablation of Locally Advanced Pancreatic Cancer with Percutaneous Irreversible Electroporation: Results of the Phase I/II PANFIRE Study. First author DOI 10.1148/radiol.2016152835↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hester J. Scheffer · 9 shared papers, 2017–2025 · strength 0.99
  2. Martijn Ruben Meijerink · 9 shared papers, 2017–2025 · strength 0.99
  3. Alette H. Ruarus · 6 shared papers, 2018–2025 · strength 0.76
  4. Tanja D. de Gruijl · 5 shared papers, 2017–2025 · strength 0.61
  5. Bart Geboers · 4 shared papers, 2019–2025 · strength 0.56
  6. Geert Kazemier M · 5 shared papers, 2017–2020 · strength 0.41
  7. Florentine E. F. Timmer · 2 shared papers, 2024–2025 · strength 0.37
  8. Anna M E Bruynzeel · 2 shared papers, 2024–2025 · strength 0.37
  9. Frank J. Lagerwaard · 2 shared papers, 2024–2025 · strength 0.37
  10. Marc G. Besselink · 3 shared papers, 2017–2020 · strength 0.25
  11. Krijn P. van Lienden · 2 shared papers, 2020 · strength 0.19
  12. Eran van Veldhuisen · 2 shared papers, 2020 · strength 0.19
  13. Marian A.E. de van der Schueren · 2 shared papers, 2017–2019 · strength 0.16
  14. Jill E. Witvliet-van Nierop · 2 shared papers, 2017–2019 · strength 0.16
  15. Babs M. Zonderhuis · 2 shared papers, 2017–2020 · strength 0.15
  16. Jantien A. Vogel · 2 shared papers, 2017–2020 · strength 0.15
  17. Nicolette Wierdsma · 1 shared paper, 2019 · strength 0.11
  18. Johanna W. Wilmink · 1 shared paper, 2020 · strength 0.09
  19. Freek D. Daams · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.